Sino Biological
30104767.500.72% ( +0.48 )
Sino Biological (301047)
Sino Biological,Inc. engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally. The compan...
- Open
- 67.33
- High
- 68.57
- Low
- 66.98
- Prev. Close
- 67.02
- Volume
- 11.99K
- Turnover
- 81.52M
- Avg Price
- 68.00
- Bid/Ask Ratio
- --
- Amplitude
- 2.37%
- 52wk High
- 83.80
- Volume Ratio
- 0.32
- Turnover Ratio
- 0.99%
Sino Biological Analyst Rating
View MoreForecast & Rating
Feb 14, 2026Price forecast
¥78.0015.56%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · May 29 at 09:43 AM
10:42 ETLa synthèse protéique acellulaire de Sino Biological appuie l'étude de conception protéique du Tencent AI for Life Sciences Lab publiée dans Nature Communications
- prnewswire · Mar 10 at 02:25 AM
03:22 ETThe 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard
- prnewswire · Mar 3 at 07:55 PM
20:53 ETAdvancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains
- prnewswire · Jan 20 at 10:17 AM
11:15 ET El lanzamiento de los kits SwiftFluo® TR-FRET de Sino Biological marca una nueva era
- Zhitong · Oct 27, 2025 at 06:49 AM
Sino Biological released its performance for the first three quarters, with a net profit attributable to the parent company of 110 million yuan, an increase of 10.94%
- Zhitong · Sep 5, 2025 at 03:03 AM
Sino Biological: The controlling shareholder Aileke pledged 3.70% of the company's shares
